Page last updated: 2024-08-23

quinapril and Scleroderma, Systemic

quinapril has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Maddison, P	1

Reviews

1 review(s) available for quinapril and Scleroderma, Systemic

Article	Year
Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition. Rheumatology (Oxford, England), 2002, Volume: 41, Issue:9 Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Humans; Isoquinolines; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Quinapril; Randomized Controlled Trials as Topic; Raynaud Disease; Registries; Scleroderma, Localized; Scleroderma, Systemic; Tetrahydroisoquinolines; United Kingdom	2002

Article

Year

Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition.

Rheumatology (Oxford, England), 2002, Volume: 41, Issue:9

Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Humans; Isoquinolines; Middle Aged; Multicenter Studies as Topic; Peripheral Vascular Diseases; Quinapril; Randomized Controlled Trials as Topic; Raynaud Disease; Registries; Scleroderma, Localized; Scleroderma, Systemic; Tetrahydroisoquinolines; United Kingdom

2002